Host–Pathogen Interaction in Invasive Salmonellosis

Salmonella enterica infections result in diverse clinical manifestations. Typhoid fever, caused by S. enterica serovar Typhi (S. Typhi) and S. Paratyphi A, is a bacteremic illness but whose clinical features differ from other Gram-negative bacteremias. Non-typhoidal Salmonella (NTS) serovars cause self-limiting diarrhea with occasional secondary bacteremia. Primary NTS bacteremia can occur in the immunocompromised host and infants in sub-Saharan Africa. Recent studies on host–pathogen interactions in Salmonellosis using genome sequencing, murine models, and patient studies have provided new insights. The full genome sequences of numerous S. enterica serovars have been determined. The S. Typhi genome, compared to that of S. Typhimurium, harbors many inactivated or disrupted genes. This can partly explain the different immune responses both serovars induce upon entering their host. Similar genome degradation is also observed in the ST313 S. Typhimurium strain implicated in invasive infection in sub-Saharan Africa. Virulence factors, most notably, type III secretion systems, Vi antigen, lipopolysaccharide and other surface polysaccharides, flagella, and various factors essential for the intracellular life cycle of S. enterica have been characterized. Genes for these factors are commonly carried on Salmonella Pathogenicity Islands (SPIs). Plasmids also carry putative virulence-associated genes as well as those responsible for antimicrobial resistance. The interaction of Salmonella pathogen-associated molecular patterns (PAMPs) with Toll-like receptors (TLRs) and NOD-like receptors (NLRs) leads to inflammasome formation, activation, and recruitment of neutrophils and macrophages and the production of pro-inflammatory cytokines, most notably interleukin (IL)-6, IL-1β, tumor necrosis factor (TNF)-α, and interferon-gamma (IFN)-γ. The gut microbiome may be an important modulator of this immune response. S. Typhimurium usually causes a local intestinal immune response, whereas S. Typhi, by preventing neutrophil attraction resulting from activation of TLRs, evades the local response and causes systemic infection. Potential new therapeutic strategies may lead from an increased understanding of infection pathogenesis.

[1]  J. Shea,et al.  Genes encoding putative effector proteins of the type III secretion system of Salmonella pathogenicity island 2 are required for bacterial virulence and proliferation in macrophages , 1998, Molecular microbiology.

[2]  P. Ricciardi-Castagnoli,et al.  Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria , 2001, Nature Immunology.

[3]  J. Tschopp,et al.  The Inflammasomes , 2010, Cell.

[4]  S. Hoffman,et al.  Reduction of mortality in chloramphenicol-treated severe typhoid fever by high-dose dexamethasone. , 1984, The New England journal of medicine.

[5]  L. Bossi,et al.  Inducible prophages contribute to Salmonella virulence in mice , 1999, Molecular microbiology.

[6]  S. Grinstein,et al.  Elimination of host cell PtdIns(4,5)P2 by bacterial SigD promotes membrane fission during invasion by Salmonella , 2002, Nature Cell Biology.

[7]  S. Akira,et al.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors , 2010, Nature Immunology.

[8]  Yanyun Zhang,et al.  Molecular analysis and identification of virulence gene on pR(ST98) from multi-drug resistant Salmonella typhi. , 2005, Cellular & molecular immunology.

[9]  A. Zychlinsky,et al.  Caspase-1-Mediated Activation of Interleukin-1β (IL-1β) and IL-18 Contributes to Innate Immune Defenses against Salmonella enterica Serovar Typhimurium Infection , 2006, Infection and Immunity.

[10]  A. Bäumler,et al.  Capsule-Mediated Immune Evasion: a New Hypothesis Explaining Aspects of Typhoid Fever Pathogenesis , 2006, Infection and Immunity.

[11]  Charles A. Janeway,et al.  IRAK-M Is a Negative Regulator of Toll-like Receptor Signaling , 2002, Cell.

[12]  R. Flavell,et al.  A Salmonella protein causes macrophage cell death by inducing autophagy , 2003, The Journal of cell biology.

[13]  N. Salzman,et al.  Prolonged Impact of Antibiotics on Intestinal Microbial Ecology and Susceptibility to Enteric Salmonella Infection , 2009, Infection and Immunity.

[14]  M. Molyneux,et al.  Invasive non-typhoid salmonellae establish systemic intracellular infection in HIV-infected adults: an emerging disease pathogenesis. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  Agneta Richter-Dahlfors,et al.  Vesicle-Mediated Export and Assembly of Pore-Forming Oligomers of the Enterobacterial ClyA Cytotoxin , 2003, Cell.

[16]  Jay K Kolls,et al.  Simian immunodeficiency virus–induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut , 2008, Nature Medicine.

[17]  S. Falkow,et al.  Salmonella typhimurium Persists within Macrophages in the Mesenteric Lymph Nodes of Chronically Infected Nramp1 + / + Mice and Can Be Reactivated by IFNγ Neutralization , 2004, The Journal of experimental medicine.

[18]  Kim Rutherford,et al.  Complete genome sequence of a multiple drug resistant Salmonella enterica serovar Typhi CT18 , 2001, Nature.

[19]  J. Bertin,et al.  Role of the caspase-1 inflammasome in Salmonella typhimurium pathogenesis , 2006, The Journal of experimental medicine.

[20]  Stephen M. Graham,et al.  Nontyphoidal salmonellosis in Africa , 2010, Current opinion in infectious diseases.

[21]  J. Bertin,et al.  Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1β in salmonella-infected macrophages , 2006, Nature Immunology.

[22]  T. van der Poll,et al.  Host-pathogen interactions in sepsis. , 2008, The Lancet. Infectious diseases.

[23]  D. Monack,et al.  Molecular mechanisms of inflammasome activation during microbial infections , 2011, Immunological reviews.

[24]  J. Meer,et al.  Patterns of proinflammatory cytokines and inhibitors during typhoid fever. , 1994, The Journal of infectious diseases.

[25]  S. Winter,et al.  The Salmonella enterica serotype Typhi regulator TviA reduces interleukin‐8 production in intestinal epithelial cells by repressing flagellin secretion , 2007, Cellular microbiology.

[26]  Guy Plunkett,et al.  Comparative Genomics of Salmonellaenterica Serovar Typhi Strains Ty2 and CT18 , 2003, Journal of bacteriology.

[27]  H. Lockman,et al.  Salmonella typhimurium mutants lacking flagella or motility remain virulent in BALB/c mice , 1990, Infection and immunity.

[28]  S. Winter,et al.  The Vi‐capsule prevents Toll‐like receptor 4 recognition of Salmonella , 2008, Cellular microbiology.

[29]  S. Winter,et al.  Clinical pathogenesis of typhoid fever. , 2008, Journal of infection in developing countries.

[30]  J. Crump,et al.  Global trends in typhoid and paratyphoid Fever. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  Zhemin Zhou,et al.  Multilocus Sequence Typing as a Replacement for Serotyping in Salmonella enterica , 2012, PLoS pathogens.

[32]  B. Taylor,et al.  Control of natural resistance to Salmonella typhimurium and Leishmania donovani in mice by closely linked but distinct genetic loci , 1980, Nature.

[33]  B. Connor,et al.  Typhoid and paratyphoid fever in travellers. , 2005, The Lancet. Infectious diseases.

[34]  J. Wain,et al.  The molecular mechanisms of severe typhoid fever. , 2001, Trends in microbiology.

[35]  Alan Aderem,et al.  Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1β via Ipaf , 2006, Nature Immunology.

[36]  C. Alpuche-Aranda,et al.  Gallstones play a significant role in Salmonella spp. gallbladder colonization and carriage , 2010, Proceedings of the National Academy of Sciences.

[37]  I. Brodsky,et al.  NLR-mediated control of inflammasome assembly in the host response against bacterial pathogens. , 2009, Seminars in immunology.

[38]  J. Farrar,et al.  Transcriptional response in the peripheral blood of patients infected with Salmonella enterica serovar Typhi , 2009, Proceedings of the National Academy of Sciences.

[39]  J. Galán,et al.  Salmonella‐induced macrophage death: multiple mechanisms, different outcomes , 2004, Cellular microbiology.

[40]  S. Winter,et al.  Salmonella, the host and its microbiota. , 2012, Current opinion in microbiology.

[41]  T. Butler,et al.  Typhoid fever. Studies of blood coagulation, bacteremia, and endotoxemia. , 1978, Archives of internal medicine.

[42]  D. Monack,et al.  Shedding light on Salmonella carriers. , 2012, Trends in microbiology.

[43]  M. Wenk,et al.  Salmonella Modulates Vesicular Traffic by Altering Phosphoinositide Metabolism , 2004, Science.

[44]  S. Falkow,et al.  Extraintestinal dissemination of Salmonella by CD18-expressing phagocytes , 1999, Nature.

[45]  Richard Bonneau,et al.  Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome , 2010, Proceedings of the National Academy of Sciences.

[46]  S. Nair,et al.  Vi Antigen Expression in Salmonella enterica Serovar Typhi Clinical Isolates from Pakistan , 2005, Journal of Clinical Microbiology.

[47]  N. Beeching,et al.  Outpatient treatment of patients with enteric fever. , 2011, The Lancet. Infectious diseases.

[48]  W. Hardt,et al.  Bacteriophage-encoded type III effectors in Salmonella enterica subspecies 1 serovar Typhimurium. , 2005, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[49]  F. Daigle,et al.  Intracellular survival of Salmonella enterica serovar Typhi in human macrophages is independent of Salmonella pathogenicity island (SPI)-2. , 2010, Microbiology.

[50]  B. Cookson,et al.  Apoptosis, Pyroptosis, and Necrosis: Mechanistic Description of Dead and Dying Eukaryotic Cells , 2005, Infection and Immunity.

[51]  J. Wain,et al.  IncHI plasmids, a dynamic link between resistance and pathogenicity. , 2008, Journal of infection in developing countries.

[52]  C. Parry,et al.  Antimicrobial resistance in typhoidal and nontyphoidal salmonellae , 2008, Current opinion in infectious diseases.

[53]  S. Nair,et al.  Emergence of a Globally Dominant IncHI1 Plasmid Type Associated with Multiple Drug Resistant Typhoid , 2011, PLoS neglected tropical diseases.

[54]  Z. Bhutta,et al.  Impact of age and drug resistance on mortality in typhoid fever. , 1996, Archives of disease in childhood.

[55]  Aamir Fazil,et al.  The global burden of nontyphoidal Salmonella gastroenteritis. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[56]  J. Wain,et al.  The role of prophage-like elements in the diversity of Salmonella enterica serovars. , 2004, Journal of molecular biology.

[57]  Nicholas A Feasey,et al.  Invasive non-typhoidal salmonella disease: an emerging and neglected tropical disease in Africa , 2012, The Lancet.

[58]  W. Nauseef,et al.  Salmonella Pathogenicity Island 2-Encoded Type III Secretion System Mediates Exclusion of NADPH Oxidase Assembly from the Phagosomal Membrane1 , 2001, The Journal of Immunology.

[59]  J. Madara,et al.  Flagellin Is the Major Proinflammatory Determinant of Enteropathogenic Salmonella1 , 2003, The Journal of Immunology.

[60]  A. Aderem,et al.  Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria , 2010, Nature Immunology.

[61]  J. Tschopp,et al.  NLRC4 inflammasomes in dendritic cells regulate noncognate effector function by memory CD8+ T cells , 2012, Nature Immunology.

[62]  Zhenghong Qin,et al.  A Salmonella enterica serovar Typhi plasmid induces rapid and massive apoptosis in infected macrophages , 2010, Cellular and Molecular Immunology.

[63]  F. Fang,et al.  Salmonella pathogenicity island 2-dependent evasion of the phagocyte NADPH oxidase. , 2000, Science.

[64]  R. Swanson,et al.  Macrophage defect and inflammatory cell recruitment dysfunction in Salmonella susceptible C3H/HeJ mice. , 1986, Cellular immunology.

[65]  R. Wilson,et al.  Complete genome sequence of Salmonella enterica serovar Typhimurium LT2 , 2001, Nature.

[66]  S. Nair,et al.  Variation in Salmonella enterica Serovar Typhi IncHI1 Plasmids during the Global Spread of Resistant Typhoid Fever , 2008, Antimicrobial Agents and Chemotherapy.

[67]  D. Monack,et al.  Salmonella persistence and transmission strategies. , 2012, Current opinion in microbiology.

[68]  Xiao-lian Zhang,et al.  Salmonella Typhi: from a Human Pathogen to a Vaccine Vector , 2008, Cellular and Molecular Immunology.

[69]  V. Dixit,et al.  Redundant roles for inflammasome receptors NLRP3 and NLRC4 in host defense against Salmonella , 2010, The Journal of experimental medicine.

[70]  M. Popoff,et al.  The Vi antigen of Salmonella typhi: molecular analysis of the viaB locus. , 1992, Journal of general microbiology.

[71]  Julian Parkhill,et al.  A Novel Linear Plasmid Mediates Flagellar Variation in Salmonella Typhi , 2007, PLoS pathogens.

[72]  J. Wain,et al.  Typhoid fever and genetic polymorphisms at the natural resistance-associated macrophage protein 1. , 2001, The Journal of infectious diseases.

[73]  A. Bäumler,et al.  From bench to bedside: stealth of enteroinvasive pathogens , 2008, Nature Reviews Microbiology.

[74]  J. Sirard,et al.  The Microbiota Mediates Pathogen Clearance from the Gut Lumen after Non-Typhoidal Salmonella Diarrhea , 2010, PLoS pathogens.

[75]  A. B. CiusnE,et al.  Typhoid fever. , 1967, The Journal of the Arkansas Medical Society.

[76]  Joshua N. Adkins,et al.  Discovery of Salmonella Virulence Factors Translocated via Outer Membrane Vesicles to Murine Macrophages , 2011, Infection and Immunity.

[77]  G. Dougan,et al.  Epidemic multiple drug resistant Salmonella Typhimurium causing invasive disease in sub-Saharan Africa have a distinct genotype. , 2009, Genome research.

[78]  J. Roth,et al.  Gut inflammation provides a respiratory electron acceptor for Salmonella , 2010, Nature.

[79]  R. Flavell,et al.  A mouse model for the human pathogen Salmonella typhi. , 2010, Cell host & microbe.

[80]  Jean-Mathieu Leclerc,et al.  So similar, yet so different: uncovering distinctive features in the genomes of Salmonella enterica serovars Typhimurium and Typhi. , 2010, FEMS microbiology letters.

[81]  T. Butler,et al.  Interleukin-6, gamma interferon, and tumor necrosis factor receptors in typhoid fever related to outcome of antimicrobial therapy , 1993, Antimicrobial Agents and Chemotherapy.

[82]  J. Farrar,et al.  Gatifloxacin versus chloramphenicol for uncomplicated enteric fever: an open-label, randomised, controlled trial , 2011, The Lancet. Infectious diseases.

[83]  S. Clare,et al.  Interleukin 18 Contributes to Host Resistance and Gamma Interferon Production in Mice Infected with VirulentSalmonella typhimurium , 1999, Infection and Immunity.

[84]  D. Monack,et al.  Contribution of Flagellin Pattern Recognition to Intestinal Inflammation during Salmonella enterica Serotype Typhimurium Infection , 2009, Infection and Immunity.

[85]  S. Porwollik,et al.  Humanized nonobese diabetic-scid IL2rγnull mice are susceptible to lethal Salmonella Typhi infection , 2010, Proceedings of the National Academy of Sciences.

[86]  J. Galán,et al.  Interaction of Salmonella with host cells through the centisome 63 type III secretion system. , 1999, Current opinion in microbiology.

[87]  T. van der Poll,et al.  The Systemic Pro-Inflammatory Response in Sepsis , 2010, Journal of Innate Immunity.

[88]  R. Alaniz,et al.  Membrane Vesicles Are Immunogenic Facsimiles of Salmonella typhimurium That Potently Activate Dendritic Cells, Prime B and T Cell Responses, and Stimulate Protective Immunity In Vivo1 , 2007, The Journal of Immunology.

[89]  J. Wain,et al.  Quantitation of Bacteria in Blood of Typhoid Fever Patients and Relationship between Counts and Clinical Features, Transmissibility, and Antibiotic Resistance , 1998, Journal of Clinical Microbiology.

[90]  S. Falkow,et al.  Persistent bacterial infections: the interface of the pathogen and the host immune system , 2004, Nature Reviews Microbiology.

[91]  N. Reiner,et al.  The Salmonella spvB virulence gene encodes an enzyme that ADP‐ribosylates actin and destabilizes the cytoskeleton of eukaryotic cells , 2001, Molecular microbiology.

[92]  J. Foster,et al.  Virulent Salmonella typhimurium has two periplasmic Cu, Zn-superoxide dismutases. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[93]  B. Stecher,et al.  The streptomycin mouse model for Salmonella diarrhea: functional analysis of the microbiota, the pathogen’s virulence factors, and the host’s mucosal immune response , 2012, Immunological reviews.

[94]  G. Dougan,et al.  The genome of Salmonella enterica serovar Typhi. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[95]  T. Wallis,et al.  Absence of All Components of the Flagellar Export and Synthesis Machinery Differentially Alters Virulence of Salmonella enterica Serovar Typhimurium in Models of Typhoid Fever, Survival in Macrophages, Tissue Culture Invasiveness, and Calf Enterocolitis , 2001, Infection and Immunity.

[96]  R. L. Santos,et al.  Animal models of Salmonella infections: enteritis versus typhoid fever. , 2001, Microbes and infection.

[97]  B. Finlay,et al.  Toll-Like Receptor 4 Dependence of Innate and Adaptive Immunity to Salmonella: Importance of the Kupffer Cell Network 1 , 2004, The Journal of Immunology.

[98]  B. Finlay,et al.  The Salmonella Effector Protein SopB Protects Epithelial Cells from Apoptosis by Sustained Activation of Akt* , 2005, Journal of Biological Chemistry.